observational
    1998

    Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia: a multicentre trial in central Europe

    Breza J, Dzurny O, Borowka A, Hanus T, Petrik R, Blane G, Chadha-Boreham H

    Published in Current Medical Research and Opinion

    Key Findings

    Two months of Tadenan 50 mg twice daily reduced IPSS by 40 percent with benefit largely sustained after a one month washout.

    Conclusions

    Open-label data support symptomatic improvement and tolerability.

    Limitations

    Open label without placebo control; sponsor funded.

    Supplements Studied

    Pygeum
    Herb

    Two months of Tadenan 50 mg twice daily reduced IPSS by 40 percent with benefit largely sustained after a one month washout.

    Study Details

    Year:1998
    Sample Size:85
    Duration:8 weeks
    Quality Score:4/10

    Access Study

    View on DOIOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.